Navigation Links
Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
Date:5/13/2009

sting treatments."

About Circassia

Circassia is a specialty biopharmaceutical company focused on the field of allergy. The company's range of allergy therapeutics utilizes its proprietary T-cell epitope desensitization technology, ToleroMune. Circassia's products offer potential major clinical benefits compared with existing therapies, and consequently have significant market opportunities. Over 150 million people suffer from allergic rhinitis in the US and Europe, and the current treatment market is approximately $12 billion per year. ToleroMune technology has additional potential regulatory and supply benefits for Circassia. Its state-of-the-art manufacturing fits with changes in the European regulatory environment, where authorities are increasingly treating allergen immunotherapies as pharmaceutical products, and eliminating the batch-to-batch potency variability that is an intrinsic feature of many currrent treatments. Circassia has a highly experienced management team with a proven track record in product development and commercialization. Having successfully completed two fundraising rounds the company is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman Sachs and Invesco Perpetual.

    For more information please visithttp://www.circassia.co.uk.

    Contacts:
    Steve Harris
    Rob Budge
    CEO RJB Communications
    Circassia
    Tel: +44(0)1865-760969
    Tel: +44(0)1865-784574


'/>"/>
SOURCE Circassia Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
2. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
3. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
4. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
5. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
6. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
9. AFFiRiS Begins Development of a Parkinsons Vaccine
10. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
11. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... TAMPA, Fla. , Sept. 3, 2015  WellCare ... that Drew Asher , senior vice president and ... Wells Fargo Securities 2015 Healthcare Conference on Wednesday, September ... The presentation will be webcast live. In addition, a ... conclusion of the live broadcast. Both the live broadcast ...
(Date:9/3/2015)... VIEJO, Calif. , Sept. 3, 2015 /PRNewswire/ ... global pharmaceutical company, and AqueSys, Inc. a private ... ocular implants that reduce intraocular pressure (IOP) associated ... into an agreement under which Allergan will acquire ... of the agreement, Allergan will acquire AqueSys for ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
... IsoRay, Inc. (AMEX: ISR ), a ... medical radioisotope applications for brain cancer, lung cancer, head ... Dwight Babcock, Chairman and Chief Executive Officer, will co-present ... TIME:  5:00 PM EST LINK:   ...
... Africa, Nov. 29, 2011   Leatt Corporation (OTC: ... a neck brace system designed to help prevent potentially ... sports, today announced the formation of an agreement with ... New Zealand. Whites Powersports has more than ...
Cached Medicine Technology:IsoRay, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st 2Leatt Announces Distribution Agreement With Whites Powersports for New Zealand Market 2
(Date:9/4/2015)... ... ... The Providence Fertility Center will host a Fertility Cocktail Hour" in Providence for ... and Time: October 8, 2015 at Waterman Grille restaurant and lounge, 4 Richmond Square, ... the basics of female fertility and egg freezing, and offer women a chance to ...
(Date:9/4/2015)... ... ... After wearing the same uniforms for six seasons, the Sprayberry High School ... assist the team, the Jones Agency, a locally owned insurance firm that serves communities ... new uniforms. , As is so often the case with high school and many ...
(Date:9/4/2015)... Dallas, Texas (PRWEB) , ... September 04, 2015 ... ... the recipient of three separate “Partner of the Year” awards at this year’s ... included being named Microsoft’s 2015 “Partner of the Year” Award Winner for Data ...
(Date:9/4/2015)... ... 2015 , ... “Getting away from the daily stressors and distractions of life ... their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort Maui ... only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in Hawaii, ...
(Date:9/4/2015)... ... 04, 2015 , ... Bio-Logic Aqua® Research, a fresh water ... only mission and research focus: Water Life Science®. In the current warming and ... is becoming dangerously accelerated. As a result of the global fresh water, water ...
Breaking Medicine News(10 mins):Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3
... a Helping Hand, WEST PALM BEACH, Fla., May ... West Palm Beach home of,the American Lung Association of ... and Quantum Foundation to partner on one of,Palm Beach ... a 6000 square foot renovation by ALAFSE using,Leadership in ...
... is female issue, though almost half, infertility cases due to male factors ... ... factors, PURCHASE, N.Y., May 30 Among couples who ... an informal web survey conducted by IntegraMed, the leading operator of,fertility centers ...
... BOSTON, May 30 On June 5th at ... shareholders will vote for the,second year on a ... Compensation., The resolution received 42% last year., ... firm focused on,integrating environmental, social and governance factors ...
... in many homes whole milk is just as effective, ... (0.1%) barium suspension that is also commonly used as an oral ... a new study finds. , The study included 215 patients undergoing ... of the study. All patients were given an IV contrast media; ...
... A team of researchers, led by Dr Nicola Wiles ... the Peninsula Medical School in the South West, has ... Health Research Health Technology Assessment (NIHR HTA) programme for ... behavioural therapy (CBT) for patients with depression who do ...
... is available in German . , Viruses ... of an infected organism. This trait is now being exploited ... cells of a patient to treat genetic diseases or genetic ... described in the journal Angewandte Chemie, they have been able ...
Cached Medicine News:Health News:2701 Australian: A Unique Partnership 2Health News:2701 Australian: A Unique Partnership 3Health News:Fertility Specialists Decry Men's Reluctance to Seek Infertility Treatment 2Health News:Fertility Specialists Decry Men's Reluctance to Seek Infertility Treatment 3Health News:£1.2M trial to test effectiveness of cognitive behavioral therapy 2Health News:Self-assembled viruses 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: